The fall in blood pressure following autonomic blockade with methonium compounds could be attributed to a fall in cardiac output or to vasodilatation. In the recumbent position, however, cardiac output is usually well-maintained (1, 2, 3, 4) and blood flow through brain (5) and kidneys (1, 6) is not greatly altered. Increased blood flow has been reported in the digits and feet (1). This would hardly account for the large fall in blood pressure, and it seemed possible that the splanchnic area might be the site of the major vasodilatation. There is little information concerning splanchnic blood flow after hexamethonium. Freis and associates (1) state that it is not significantly changed, while Hoobler is said to have found a fall after tetraethylammonium chloride (7). We have therefore studied the effect of hexamethonium on splanchnic blood flow in subjects without liver disease. The opportunity has also been taken to make observations on the metabolic effects of hexamethonium on splanchnic oxygen consumption, hepatic glucose output and arterial lactic acid concentration.
The fall in blood pressure following autonomic blockade with methonium compounds could be attributed to a fall in cardiac output or to vasodilatation. In the recumbent position, however, cardiac output is usually well-maintained (1, 2, 3, 4) and blood flow through brain (5) and kidneys (1, 6) is not greatly altered. Increased blood flow has been reported in the digits and feet (1) . This would hardly account for the large fall in blood pressure, and it seemed possible that the splanchnic area might be the site of the major vasodilatation. There is little information concerning splanchnic blood flow after hexamethonium. Freis and associates (1) state that it is not significantly changed, while Hoobler is said to have found a fall after tetraethylammonium chloride (7) . We have therefore studied the effect of hexamethonium on splanchnic blood flow in subjects without liver disease. The opportunity has also been taken to make observations on the metabolic effects of hexamethonium on splanchnic oxygen consumption, hepatic glucose output and arterial lactic acid concentration.
METHODS AND MATERIAL
The 17 subjects had no known hepatic dysfunction or disturbance of carbohydrate metabolism, and had not previously received hexamethonium. Five had essential hypertension with diastolic blood pressures between 90 and 110 mm. Hg. Studies were made in the morning after an overnight fast, and one hour after an oral dose of 0.2 Gm. sodium amytal. A radio-opaque nylon catheter was introduced under fluoroscopic control into a radicle of the hepatic vein, and the subjects were then returned to a comfortable position in bed with the head on one small pillow. A priming dose of bromsulphalein (B.S.P.) 1 Estimated splanchnic blood flow (E.S.B.F.) was calculated with appropriate corrections for changing plasma B. S. P. levels (8) . Plasma levels over 1 mg. per cent were maintained in all instances and extraction by the liver always exceeded 15 per cent. Plasma B.S.P. levels tended to rise after hexamethonium because of the marked fall in E.S.B.F. Decreasing the infusion rate by 20 to 30 per cent at the time of giving the hexamethonium usually prevented this rise. If the B.S.P. level five minutes after hexamethonium had risen in spite of this, the determination was discarded.
Hepatic glucose output (HGO) was determined by multiplying the arterial-hepatic vein glucose difference by the E.S.B.F. For the control value the average of the three or four arteriovenous glucose differences was multiplied by the average value for blood flow. Intestinal and splenic metabolism of glucose is probably negligible in the fasting state (9, 10) and the term "hepatic" rather than "splanchnic" glucose output has therefore been used throughout.
"Mean" blood pressure was expressed as half the sum of the systolic and diastolic auscultatory levels. In certain subjects this was checked by direct tracings obtained by strain gauge from the in-dwelling arterial needle.
Overall splanchnic vascular resistance was calculated by dividing the "mean" blood pressure (mm. Hg) by the splanchnic blood flow (ml. per min.) and expressed in arbitrary units.
"Portal venous pressure" was measured with a strain gauge in six subjects before and after hexamethonium by 793 the technique of "occluded" hepatic vein catheterization (11, 12, 13) , the catheter being advanced deep into the substance of the liver so as to occlude an hepatic vein. A close correlation has been found between the pressure recorded in this position and the portal venous pressure (13) . These six subjects remained recumbent on the padded fluoroscopy table throughout the study. Blood samples were preserved with heparin and sodium fluoride. Glucose was measured on duplicate 0.2 ml. whole blood samples (14) , bromsulphalein on 1 or 2 ml. of plasma (15) and lactic acid on 2 ml. of whole blood (16). Oxygen unsaturation was determined without delay on 5 ml. blood samples collected under paraffin using the Haldane blood gas apparatus (17) . Plasma volume (18) and surface area were calculated from tables. (Table I) In 15 subjects the reaction to hexamethonium was similar ( Figure 1 ). The "mean" blood pressure fell within 5 minutes, and within 30 minutes had reached levels averaging 32 per cent below the control value. A fall in blood pressure occurred in all subjects, even though recumbent. The magnitude of the fall varied considerably, being greatest in those with the highest resting values.
RESULTS

Changes in Splanchnic Circulation
Pulse rate increased by an average of 11 per cent of the resting value.
E.S.B.F. initially was slightly higher than previously reported values for normal subjects under similar conditions (15) . After hexamethonium the E.S.B.F. fell, reaching an average of 67 per cent of the control value at the end of 30 minutes. The fall in E.S.B.F. paralleled the fall in "mean" blood pressure and the correlation coefficient, being more than six times its standard error, was therefore highly significant ( Figure 2 Arterial-hepatic venous oxygen difference increased significantly (Figure 1 ). This increase was entirely due to a drop in hepatic venous oxygen content, for arterial oxygen unsaturation did not change during the course of the study. It coincided in time with the fall in "mean" blood pressure and in E.S.B.F. "Portal Vein Pressure" (Table II) In six subjects the "portal venous pressure" measured by the "occluded" hepatic vein technique fell after hexamethonium. The degree of fall in pressure varied considerably and was unrelated to the fall in E.S.B.F.
Observations during Second Hour
In six subjects in whom observations were continued for a second hour, the fall in blood pressure and E.S.B.F. and the increase in arterial-hepatic venous oxygen difference were maintained, with only a slight return towards control values.
Anomalous Results
Two subjects reacted in a different manner (T. A., H. H., Table I ). After a brief initial drop, E.S.B.F. rose moderately and was accompanied by a fall in arterial-hepatic venous oxygen difference. Since the blood pressure fell, there was a drop in estimated splanchnic resistance, indicating splanchnic vasodilatation. There was no obvious explanation for this anomalous behaviour. (Table III) Splanchnic oxygen consumption calculated by multiplying E.S.B.F. by the arterial-hepatic venous oxygen difference did not change significantly during the hour following hexamethonium. Hepatic glucose output. The basal glucose output of 120 mg. per min. per sq. meter agrees well with previous findings (20) . There were considerable fluctuations in output following hexamethonium, the mean values being higher than the basal output except at 30 minutes. The changes, however, were not statistically significant.
Changes in Splanchnic Metabolism
Arterial blood glucose concentration increased slightly, but again the change was not statistically significant.
Arterial lactic acid concentration rose from 8.2 mg. per cent to a maximum of 9.7 mg. per cent. This change was of doubtful significance.
DISCUSSION
The fall in E.S.B.F. after hexamethonium correlated well with the fall in "mean" blood pressure (Figure 2) , and there was therefore little change in calculated splanchnic vascular resistance. Appreciable splanchnic vasodilatation apparently did not occur and splanchnic blood flow fell as a direct consequence of the drop in arterial pressure. This is rather surprising inasmuch as changes in capacity of the splanchnic bed have long been thought to play an important part in the production of the hypotensive state. The present results could have two interpretations. The dose of hexamethonium employed might have failed to block the splanchnic sympathetic ganglia. This could hardly be true of sympathetic ganglia elsewhere, for, the general blood pressure fell markedly. Alternatively, splanchnic vasodilatation produced by hexamethonium might have been balanced by splanchnic vasoconstriction, in response to hypotension. For example, the hypotension initiated by changing from the recumbent to the erect posture is prevented by reflex splanchnic vasoconstriction (19) . The hypotension following hexamethonium might also be balanced in this way, although this could hardly have been mediated through autonomic ganglia which are presumably already blocked.
Whatever the mechanism, the fall in E.S.B.F. was not associated with overall changes in the capacity of the splanchnic vascular bed.
Changes in splanchnic blood flow could, of course, be due to alterations in resistance in any S. */ -. . Additional evidence for the fall in splanchnic blood flow was afforded by the arterial-hepatic venous oxygen difference. If oxygen utilization by the splanchnic area is unchanged (Table II) , then the arterial-hepatic venous oxygen difference should vary inversely with the splanchnic blood flow. This in fact proved to be the case ( Figure  3 ). The mean rise in arterial-hepatic venous oxygen difference was 31 per cent, a similar figure to that obtained for E.S.B.F. by the B.S.P. clearance technique.
The effects of hexamethonium on the splanchnic area appear to be limited to changes in circulation. Changes in hepatic glucose output and arterial glucose concentration did not occur. The failure of arterial lactic acid concentrations to rise appreciably indicates that the basal state of the subjects was maintained, since blood lactic acid increases rapidly following muscular activity or release of epinephrine (22) .
SUMMARY
The effect of hexamethonium bromide (1 mg. per Kg. intramuscularly) on the splanchnic circulation, splanchnic oxygen consumption, hepatic glucose output and arterial lactic acid concentration was measured in 17 subjects.
In 15 subjects splanchnic blood flow fell in proportion to the fall in arterial blood pressure. No change occurred in splanchnic vascular resistance, indicating that there was no splanchnic vasodilatation.
In two subjects splanchnic blood flow rose, together with a fall in splanchnic vascular resistance.
Splanchnic oxygen consumption, hepatic glucose output and arterial glucose and lactic acid concentrations were not significantly altered.
